← All companiesXXenon Pharmaceuticals Inc.
XENE - CIK 0001582313
Xenon Pharmaceuticals Inc. net income by year
Xenon Pharmaceuticals Inc. (XENE) reported net income of -$345.91M for fiscal year 2025, as filed in its audited annual report with the SEC.
XENE annual net income
XENE net income 2012-2025
| Fiscal year | Net Income | Change |
|---|
| FY 2025 | -$345.91M | -47.6% |
| FY 2024 | -$234.33M | -28.5% |
| FY 2023 | -$182.39M | -45.5% |
| FY 2022 | -$125.37M | -58.9% |
| FY 2021 | -$78.88M | -173.5% |
| FY 2020 | -$28.84M | +30.7% |
| FY 2019 | -$41.59M | -20.6% |
| FY 2018 | -$34.50M | -12.4% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does Xenon Pharmaceuticals Inc. make?
Xenon Pharmaceuticals Inc. (XENE) reported net income of -$345.91M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Xenon Pharmaceuticals Inc.'s net income changed over time?
Between fiscal 2012 and fiscal 2025, Xenon Pharmaceuticals Inc.'s net income declined from -$4.30M to -$345.91M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.